<DOC>
	<DOC>NCT01613183</DOC>
	<brief_summary>The objective of this study is to screen the effective core formulation in insomnia treatment with Chinese medicine with a double-blind, randomized, placebo-controlled trial.</brief_summary>
	<brief_title>Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>aged between 18 and 65 years, meeting the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSMV) of insomnia, Spiegel scale score is ≥ 18, The informed consent must be obtained from patient total sleep time ≤ 2 hours, secondary insomnia, Selfrating Anxiety Scale (SAS) score ≥ 18, Beck Depression Inventory (BDI) score ≥ 6, having hypertension, diabetes, stroke, and coronary heart disease, have drug abuse history, pregnancy or preparing to pregnancy, used immunotherapy or hormone therapy in past 1 years, participating in another clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>